Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry | PLOS ONE
![Exploring the dark side of the immune microenvironment in Follicular Lymphoma | Research Communities by Springer Nature Exploring the dark side of the immune microenvironment in Follicular Lymphoma | Research Communities by Springer Nature](https://images.zapnito.com/uploads/5sSQAOxRYOsJNS42Alg3_visual%20abstract_blood2021.jpg)
Exploring the dark side of the immune microenvironment in Follicular Lymphoma | Research Communities by Springer Nature
![The Follicular Lymphoma International Prognostic Index (FLIPI) as Part of a Proposed Prognostic Model for Follicular Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (ASCT). - ScienceDirect The Follicular Lymphoma International Prognostic Index (FLIPI) as Part of a Proposed Prognostic Model for Follicular Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (ASCT). - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497118639102-gr1.jpg)
The Follicular Lymphoma International Prognostic Index (FLIPI) as Part of a Proposed Prognostic Model for Follicular Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (ASCT). - ScienceDirect
![Table 1 from Guidelines for the diagnosis and treatment of follicular lymphoma in China | Semantic Scholar Table 1 from Guidelines for the diagnosis and treatment of follicular lymphoma in China | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8279c2698ead2cc01d1127199ea01c860cf8d587/2-Table1-1.png)
Table 1 from Guidelines for the diagnosis and treatment of follicular lymphoma in China | Semantic Scholar
![The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin ... The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin ...](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120526177-gr1.jpg)
The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin ...
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy | Haematologica
![Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden | Journal of Cancer Research and Clinical Oncology Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-022-04138-3/MediaObjects/432_2022_4138_Fig5_HTML.png)
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden | Journal of Cancer Research and Clinical Oncology
![A patient with bulky Stage III, Grade 3A, FLIPI high-risk follicular lymphoma with night sweats and weight loss | Research To Practice A patient with bulky Stage III, Grade 3A, FLIPI high-risk follicular lymphoma with night sweats and weight loss | Research To Practice](http://www.researchtopractice.com/sites/default/files/2015/Hematologic/iPOCNHL15/Images/Slide18.jpg)
A patient with bulky Stage III, Grade 3A, FLIPI high-risk follicular lymphoma with night sweats and weight loss | Research To Practice
![ottobre 2018 - Nuovo score prognostico semplificato per pazienti affetti da linfoma follicolare de novo che necessitino di trattamento immuno-chemioterapico ottobre 2018 - Nuovo score prognostico semplificato per pazienti affetti da linfoma follicolare de novo che necessitino di trattamento immuno-chemioterapico](https://grandangoloinematologia.accmed.org/images/asset/ematologia/2018-10/GA_ema18-3.12.png)
ottobre 2018 - Nuovo score prognostico semplificato per pazienti affetti da linfoma follicolare de novo che necessitino di trattamento immuno-chemioterapico
prepSSM - FLIPI FLIPI2 La disponibilità negli ultimi anni di trattamenti più efficaci nei confronti dei linfomi indolenti ha messo in luce la necessità di disporre di parametri di valutazione prognostica affidabili
![Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-07-00026/article_deploy/html/images/diagnostics-07-00026-g003.png?1569345241)
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
![Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden | Journal of Cancer Research and Clinical Oncology Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-022-04138-3/MediaObjects/432_2022_4138_Fig4_HTML.png)
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden | Journal of Cancer Research and Clinical Oncology
![Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram](https://www.researchgate.net/publication/51535872/figure/fig3/AS:305826607714311@1449926153958/Outcome-and-risk-of-lymphoma-progression-according-a-risk-groups-as-defined-by-FLIPI-2.png)
Outcome and risk of lymphoma progression according a risk groups as... | Download Scientific Diagram
![regression - Deriving life expectancy from FLIPI index data for FLIPI(3) High Risk - Cross Validated regression - Deriving life expectancy from FLIPI index data for FLIPI(3) High Risk - Cross Validated](https://i.stack.imgur.com/aj1rS.jpg)
regression - Deriving life expectancy from FLIPI index data for FLIPI(3) High Risk - Cross Validated
![Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-07-00026/article_deploy/html/images/diagnostics-07-00026-g002b.png?1569345241)